Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy

Press/Media

Period	Mar 3 2022

Media coverage

Title	Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy
Media name/outlet	MOLECULAR CANCER
Country/Territory	United Kingdom
Date	03/3/22
URL	https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-021-01487-4
Persons	Y. Lynn Wang